Original Research

Omalizumab Treatment for Severe Atopic Asthma in a Real World Montréal Cohort

16 January 2018 | David Haile-Meskale, Ron Olivenstein, Toby Mcgovern, Cathy Fugere, James G. Martin
Severe atopic asthma is poorly controlled with standard treatments, including optimally dosed corticosteroids. A humanized monoclonal antibody binding immunoglobulin E, omalizumab, is approved by the US Food and Drug Administration to treat poorly controlled asthma with elevated serum IgE levels.

Assessing and Improving Processes and Outcomes of the McGill Primary Health Care Research Network

03 November 2017 | Zhida Shang, Justin Gagnon, Vera Granikov, Rosario Rodiguez, Pierre Pluye
Researcher-clinician partnerships as an approach to improving clinical practice have grown in popularity in recent years. An example of such a collaboration is the McGill Primary Health Care Research Network (hereinafter called the Network).